The second installment in a 3-part series focusing on obesity was recently published in Biochemical Pharmacology, largely devoted to examining the evidence for the obesogen hypothesis, i.e., the proposal that environmental chemicals play a role in the growing overweight/obesity pandemic. This review specifically defines obesogens as chemicals that increase white adipose tissue massRead
Word is starting to spread that even in people whose blood glucose is within a healthy range, chronically elevated insulin can be a major factor in cardiometabolic disease. Metabolic syndrome and PCOS are the most obvious manifestations of hyperinsulinemia, but a growing number and a widening range of diverse conditions can be added toRead
Archeologists have unearthed areas of mercury pollution beneath the soil where ancient Maya civilizations lived — the pollution is so heavy that it poses a potential health hazard even today. According to a review article in Frontiers in Environmental Science, mercury pollution can be traced back to the Maya ofRead
A large body of evidence supports the use of very low-carbohydrate ketogenic diets for weight loss, reversing metabolic syndrome, putting type 2 diabetes into remission, and improving a long list of other issues. And while most individuals who adopt this way of eating experience a decrease in total cholesterol andRead
In a recently published Frontiers in Medicine review, the bidirectional interactions between environmental toxicants and the gut microbiota were examined, highlighting the complex relationship between the composition of the microbiota and xenobiotic metabolism. Given that for most people the greatest source of exposure to pollutants is via diet and waterRead
Speaker: Mark Campbell Force, DC Chemical intolerance is often the common denominator for patients with chronic and complex illnesses that frustrate clear diagnoses and are unresponsive to care. How common? Research indicates that one in five patients are seeking care because of chemical intolerance. Learn how to screen patientsRead
Non-alcoholic fatty liver disease (NAFLD) — a buildup of fat cells in the liver — affects up to 25% of people worldwide and is the most common chronic form of liver disease. There are now more reasons than ever to protect your liver: patients with fatty liver disease may face aRead
Fasting and energy-restricted diets have been evaluated in several studies as a means of improving cardiometabolic biomarkers related to body fat loss. However, further investigation is required to understand potential alterations of leptin and adiponectin concentrations. Thus, we performed a systematic review and meta-analysis to derive a more precise estimateRead
Featuring the MetabolicBiome™ Plus Program Join Dr. Alex Vasquez as he embarks on a journey to redefine metabolic health and weight loss to include dietary and metabolic insults, microbial imbalance and an increased toxic load. In this webinar, Dr. Vasquez explains the integral relationships between the gut microbiome, inflammatory status and metabolicRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
